BOSTON,
Feb. 24, 2022
/PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading
horizontal platform for cell programming, announced today that
management is scheduled to participate in the following upcoming
conferences:
- Truist Securities AI Symposium - Biotech &
Tools on Tuesday, March 1,
2022, at 9:00 a.m. ET
- Cowen 42nd Annual Health Care
Conference
-
- Fireside chat on Tuesday, March 8,
2022, at 2:10 p.m. ET
- Synthetic Biology Enabling Drug Discovery panel on Tuesday, March 8, 2022, at 3:30 p.m. ET
- HSBC Build with Bio Conference on Thursday, March 10, 2022, at 8:30 a.m. ET
Further details, webcast links, and replays of the
presentations, if available, can be accessed on the company's
investor relations website
at https://investors.ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization, and therapeutics discovery. For more information,
visit https://www.ginkgobioworks.com/.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-participation-in-upcoming-conferences-301489421.html
SOURCE Ginkgo Bioworks